Subsidy Information and Financing Scheme MAFMycophenolate Sodium Enteric-Coated Tablet 180 mg, 360 mg Prevention of organ rejection in patients who have received a kidney transplant and are unable to t... See all × MAFMycophenolate Sodium Enteric-Coated Tablet 180 mg, 360 mg Prevention of organ rejection in patients who have received a kidney transplant and are unable to tolerate mycophenolate mofetil due to gastrointestinal adverse effects.
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Enteric-Coated Tablet 180 mg National Cancer Centre National Heart Centre National University Hospital Singapore General Hospital Tan Tock Seng Hospital Woodlands Health Campus Enteric-Coated Tablet 360 mg Changi General Hospital National Cancer Centre National Heart Centre National University Hospital Singapore General Hospital Tan Tock Seng Hospital Woodlands Health Campus
ORAL Select a brand starting with the letter: A M ACCOCEPT 180 GASTRO-RESISTANT TABLET 180 MG [SIN16788P] ACCOCEPT 360 GASTRO-RESISTANT TABLET 360 MG [SIN16787P] MOFECON-GR 180 GASTRO-RESISTANT TABLETS 180 MG [SIN16969P] MOFECON-GR 360 GASTRO-RESISTANT TABLETS 360 MG [SIN16970P] MUREST-DR 180 DELAYED-RELEASE TABLETS 180MG [SIN16638P] See all MUREST-DR 360 DELAYED-RELEASE TABLETS 360MG [SIN16637P] MYFORTIC GASTRO-RESISTANT TABLET 180 MG [SIN12376P] MYFORTIC GASTRO-RESISTANT TABLET 360 MG [SIN12377P]